Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases.

Biotechnology

Education

Kyverna Therapeutics

Kyverna Therapeutics' headquarters in Emeryville, CA, United States

Warner Biddle

Dominic Borie

Jason Chan

Roy Thomas

Nadia Dac

Marc Grasso

Nancy Boman M.D.

Cara Bauer

Carrie Iriki

Dan Maziasz

Sham Dholakia

Mayo Pujols

Julia Winter

Tracy Rossin

Wyatt Luenenborg

Karen Walker

Beth Seidenberg

Ignacio Sanz

Ian Clark

Fred Cohen

Brian Kotzin

Georg Schett

Dan Spiegelman

Peter A. Merkel

Steve Liapis

The Research and Development team at Kyverna Therapeutics is dedicated to innovating and refining cell therapies for inflammatory and autoimmune diseases. Comprised of scientists and specialized researchers, the team focuses on designing experiments, developing processing techniques, and advancing the understanding of T cell immunology to optimize therapeutic efficacy and safety. Their work is crucial in translating scientific discoveries into viable clinical applications, paving the way for curative treatment options.

Research and Development

The Clinical Operations team at Kyverna Therapeutics is responsible for the planning, execution, and management of clinical trials for innovative cell therapies targeting inflammatory and autoimmune diseases. This team ensures that studies are conducted efficiently, adhering to regulatory guidelines and safety protocols, while collaborating closely with cross-functional teams to drive the development of groundbreaking living medicines.

Clinical Operations

This department focuses on ensuring compliance and maintaining high standards in quality systems and processes.

Quality Assurance

This department focuses on conducting and overseeing clinical studies to evaluate new medical treatments and interventions.

Clinical Research

The Leadership Team at Kyverna Therapeutics is responsible for steering the company’s strategic vision and operations in the development of innovative cell therapies. This team comprises leaders from diverse disciplines, including research and development, medical affairs, and finance, who collaboratively drive the advancement of curative living medicines for inflammatory and autoimmune diseases. Their collective expertise ensures effective decision-making, resource allocation, and alignment with regulatory standards to meet the company's goals.

Leadership Team

This department is responsible for ensuring that products meet all regulatory requirements throughout the development and approval processes.

Regulatory Affairs

Kyverna Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Quality Assurance

Clinical Research

Leadership Team

Regulatory Affairs

Offices

Kyverna Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Quality Assurance

Clinical Research

Leadership Team

Regulatory Affairs

Offices

Related companies